Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a monoclonal gammopathy, which is a condition where abnormal proteins are produced by blood cells (examples include AL amyloidosis, MGUS, multiple myeloma, or similar conditions)
- People who are already scheduled to have a blood sample taken from a vein, and possibly also a bone marrow sample, as part of their usual care
- People who are 18 years of age or older
- People who are willing to sign a consent form allowing their clinical information and leftover diagnostic samples to be used for research
Who may not be able to join:
- People who do not have a diagnosis of monoclonal gammopathy
- People whose condition has reached a complete response to treatment, meaning all detectable signs of the abnormal protein have disappeared after therapy (confirm with trial site)
- People under 18 years of age
- People who are not willing to allow their clinical data and leftover diagnostic samples to be used for research purposes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dataset of full-length LC variable region sequences
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.